ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Takeda ditches late-stage Ninlaro trial
June 11, 2019Takeda has announced the premature ending of its Phase 3 TOURMALINE-AL1 clinical trial in patients with relapsed or refractory systemic light-chain (AL) amyloidosis, due to the study not meeting the first of two primary endpoints. -
Evolution Research Acquires Finger Lakes Clinical Research
April 02, 2019Specializes in pediatric and adult central nervous system trials for major national and international pharmaceutical firms -
AbbVie halts late-stage TAHOE study of Rova-T in small-cell lung cancer
December 06, 2018AbbVie on Wednesday announced that it was stopping enrolment of the Phase III TAHOE study assessing rovalpituzumab tesirine, also known as Rova-T, as a second-line treatment for patients with advanced small-cell lung cancer.
Pharma Sources Insight January 2025
